High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behcet retinitis

J. Brian Reed, Lawrence S Morse, Ivan R. Schwab

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

PURPOSE: To report the response of acute Behcet retinitis to high-dose corticosteroids. METHOD: Case report. A 58-year-old man with Behcet disease and severe bilateral glaucoma experienced a sudden decrease of visual acuity to counting fingers in his (better-seeing) left eye. Examination disclosed hypopyon uveitis and an infiltrative retinitis threatening the fovea. He received intravenous methylprednisolone hemisuccinate, 1 gram per hour on each of 3 successive days, followed by oral prednisone and cyclosporine. RESULTS: The retinal infiltrate disappeared within 24 hours. Visual acuity improved to LE, 20/400 by day 5 and returned to LE, 20/30 after 3 months. A visual field demonstrated a scotoma corresponding to the location of the previous retinitis. CONCLUSION: High-dose intravenous methylprednisolone can reverse severe vision loss in acute Behcet retinitis.

Original languageEnglish (US)
Pages (from-to)409-411
Number of pages3
JournalAmerican Journal of Ophthalmology
Volume125
Issue number3
DOIs
StatePublished - Mar 1998

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behcet retinitis'. Together they form a unique fingerprint.

  • Cite this